$PDMI: Add This Sub Penny Stock to Your Watchlist
March 11th, 2010 at 9:00 am Posted by
If you’re paying attention to stock picks on the move, then you might have heard a thing or two about $PDMI in the past week.
Paradigm Medical Industries, Inc.(OTC: PDMI.PK) develops, manufactures, sources, markets and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products.
The Dean believes $PDMI is a sub penny stock for the entire student body to watch because the company recently reported its Italian partner, Costruzione Strumenti Oftalmici (CSO), completed and submitted application for FDA approval for the company’s Retimax, also known as Paramax.
In the release, $PDMI‘s President and CEO Stephen Davis said “this new innovative device offers the earliest detection of glaucoma currently available and will be an excellent addition to Paradigm’s glaucoma diagnostic products.”
$PDMI is also the exclusive representative for this “significant new product” in the United States, where more than 2.2 million people have glaucoma.
Overall, The Dean believes there’s been a lot of recent excitement in $PDMI‘s trading volume but this penny stock has settled down and could be ripe for the picking.
The Dean wants all of his students to do their homework and think about this: what happens when you combine a sub-penny stock with a product that’s pending FDA approval? The Dean thinks you should definitely add it to your watchlist.
